Urinary tract infection (lower) - women - Management

Size: px
Start display at page:

Download "Urinary tract infection (lower) - women - Management"

Transcription

1 Urinary tract infectin (lwer) - wmen - Management Scenari: Cystitis in wmen wh are nt pregnant Hw shuld I manage a wman with suspected cystitis? Cnvey a psitive apprach and reassure the wman that cystitis is generally self-limiting. Withut antibitics, symptms can be expected t reslve in 4 9 days. With antibitics, symptms can be expected t reslve in 3 8 days. On average, antibitics shrten the duratin f symptms by abut a day. Relieve symptms with paracetaml r ibuprfen d nt recmmend urine alkalinizing agents r cranberry prducts. If cystitis symptms are mderate r severe: Offer an antibitic. D nt dipstick test the urine, as the decisin t ffer an antibitic is nt influenced by urine dipstick test results. Even if the tests fr nitrite, and leuccyte esterase, and bld are all negative, an antibitic shuld still be ffered. If the wman prefers nt t take an antibitic, ffer a delayed antibitic prescriptin t be dispensed if the symptms becme wrse, r last mre than 48 hurs. If cystitis symptms are mild: Dipstick test the urine t guide treatment decisins. Discuss nt using an antibitic, especially if the urine dipstick test is negative fr nitrites and leuccyte esterase and bld. Have a lwer threshld fr ffering an antibitic if there are risk factrs fr persistent infectin, recurrent infectin, r treatment failure. If there are cncerns abut nt taking an antibitic, ffer a delayed antibitic prescriptin t be dispensed if the symptms becme wrse, r last mre than 48 hurs. Advise the wman t seek medical attentin if she develps a high fever r becmes systemically unwell. In depth 1

2 When prescribing empirically fr acute cystitis which antibitic shuld I chse? Fllw lcal guidelines when available. If lcal guidelines are nt available: Fr an uncmplicated infectin, prescribe either: Trimethprim 200 mg twice daily, fr 3 days, r Nitrfurantin 50 mg fur times daily, r 100 mg (mdified-release) twice daily, fr 3 days. Fr a cmplicated infectin, prescribe a 5 10-day curse f trimethprim r nitrfurantin. In depth When shuld I culture the urine f a wman with suspected cystitis? Urine micrscpy and culture are nt rutinely required fr wmen with uncmplicated cystitis. Send urine fr micrscpy and culture if any f the fllwing apply: There are risk factrs fr a cmplicated urinary tract infectin fr example the wman has recently had urlgical instrumentatin, r is immuncmprmised, r has been in hspital recently. Cnfirmatin f the diagnsis r exclusin f ther cnditins is required. The wman has nt respnded t antibitic treatment. The wman has recurrent episdes f cystitis and this has nt been investigated. When underlying causes f recurrent cystitis and ther cnditins have been excluded, it is nt necessary t rutinely culture the urine fr further episdes. In depth Hw shuld I fllw up a wman with cystitis? Fllw up is nt rutinely required fr uncmplicated cystitis, but shuld be cnsidered fr wmen with a ptentially cmplicated infectin. If haematuria was fund, fllw up t re-test the urine and check that the infectin and haematuria have reslved. In depth 2

3 When shuld I refer a wman with acute cystitis? If the wman fails t respnd t tw curses f antibitics shwn by urine culture results t be apprpriate treatment, refer fr specialist assessment. If urlgical cancer is suspected (fr example haematuria persists after successful treatment f cystitis), refer urgently t a team specializing in the management f urlgical cancer. In depth Hw shuld I manage a wman whse cystitis has failed t respnd t antibitics? Cntinue symptmatic treatment with paracetaml r ibuprfen. Check cmpliance with antibitic treatment. Send a urine sample fr culture. If symptms are trublesme, ffer a different antibitic (nitrfurantin r trimethprim) while waiting fr the culture results see Chice f antibitic. If infectin is cnfirmed n culture, treat with an antibitic t which the rganism is sensitive. If infectin is nt cnfirmed n culture, cnsider ther pssible causes fr the symptms see Differential diagnsis. If cystitis symptms fail t respnd t tw curses f antibitic shwn by culture t be apprpriate treatment, refer fr specialist assessment. In depth Prescriptins Antibitic treatment (UTI): trimethprim and nitrfurantin Age frm 14 years nwards Trimethprim tablets: 200mg twice a day fr 3 days Trimethprim 200mg tablets Take ne tablet twice a day fr 3 days. Supply 6 tablets. Trimethprim tablets: 200mg twice a day fr 7 days Trimethprim 200mg tablets Age: frm 14 years nwards NHS cst:

4 Take ne tablet twice a day fr 7 days. Supply 14 tablets. Age: frm 14 years nwards NHS cst: 0.91 Nitrfurantin tablets: 50mg fur times a day fr 3 days Nitrfurantin 50mg tablets Take ne tablet fur times a day fr 3 days. Supply 12 tablets. Age: frm 14 years nwards NHS cst: 1.21 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin tablets: 50mg fur times a day fr 7 days Nitrfurantin 50mg tablets Take ne tablet fur times a day fr 7 days. Supply 28 tablets. Age: frm 14 years nwards NHS cst: 2.83 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 50mg fur times a day fr 3 days Nitrfurantin 50mg capsules Take ne capsule fur times a day fr 3 days. Supply 12 capsules. Age: frm 14 years nwards NHS cst: 1.00 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 50mg fur times a day fr 7 days Nitrfurantin 50mg capsules Take ne capsule fur times a day fr 7 days. Supply 28 capsules. Age: frm 14 years nwards NHS cst: 2.32 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin m/r caps: 100mg twice a day fr 3 days Nitrfurantin 100mg mdified-release capsules Take ne capsule twice a day fr 3 days. Supply 6 capsules. Age: frm 14 years nwards NHS cst: 2.10 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin m/r caps: 100mg twice a day fr 7 days 4

5 Nitrfurantin 100mg mdified-release capsules Take ne capsule twice a day fr 7 days. Supply 14 capsules. Age: frm 14 years nwards NHS cst: 4.89 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Analgesia: use when required Age frm 16 years nwards Ibuprfen tablets: 200mg t 400mg three t fur times a day Ibuprfen 200mg tablets Take ne r tw tablets 3 t 4 times a day when required fr pain relief. D nt exceed the stated dse. Supply 56 tablets. Paracetaml tablets: 500mg t 1g up t fur times a day Age: frm 16 years nwards NHS cst: 1.38 OTC cst: 2.38 Paracetaml 500mg tablets Take ne r tw tablets every 4 t 6 hurs when required fr pain relief. Maximum f 8 tablets in 24 hurs. Supply 50 tablets. Urinary tract infectin (lwer) - wmen - Management Scenari: Recurrent cystitis in wmen wh are nt pregnant Hw shuld I manage an acute episde f recurrent cystitis? Age: frm 16 years nwards NHS cst: 0.78 OTC cst: 1.35 Review the diagnsis. Culture the urine t cnfirm infectin and exclude ther causes. Refer urgently if urlgical cancer is suspected. Review the wman's medical and surgical histry t assess risk factrs fr recurrent cystitis such as stnes, papillary necrsis, and vesicureteric reflux this assessment may require imaging and urlgical referral. Relieve symptms with paracetaml r ibuprfen. If symptms are mderate r severe, ffer an antibitic immediately. 5

6 If symptms are mild, suggest delaying antibitic treatment until culture results are available t guide chice f antibitic. Advise n lifestyle measures such as high-strength cranberry capsules t reduce the risk f recurrent episdes. If trublesme cystitis recurs frequently: Cnsider ffering a prescriptin fr a 'stand-by' antibitic t be used fr future episdes. Cnsider preventive treatments. Refer r seek specialist advice if these measures are nt successful. In depth Which antibitic shuld I prescribe fr a wman with recurrent cystitis? Fllw lcal guidelines when available. Otherwise: Fr empirical treatment, prescribe either: Trimethprim 200 mg twice daily, fr 3 days, r Nitrfurantin 50 mg fur times daily, r 100 mg (mdified-release) twice daily, fr 3 days. If the wman has been treated with trimethprim recently (up t a year previusly), cnsider prescribing nitrfurantin instead f trimethprim. In depth What lifestyle measures shuld I advise fr preventing cystitis? Advise wmen with recurrent cystitis that: Cranberry prducts reduce the recurrence rate f cystitis, and are available frm shps (but nt n the NHS). Cranberry prducts shuld nt be taken if warfarin is being used. High strength capsules (cntaining at least 200 mg f cranberry extract) are recmmended because they may be mre effective and acceptable than cranberry juice. If cystitis is related t sexual intercurse, advise: Using a different cntraceptive methd if a diaphragm is being used. 6

7 Viding sn after intercurse. Using a lubricant if symptms culd be due t mild trauma rather than infectin. In depth When shuld I ffer preventive treatments fr recurrent cystitis? Cnsider ffering a prescriptin fr a 'stand-by' antibitic t be used fr future episdes f cystitis befre prescribing prphylactic drug treatment. When deciding t ffer prphylactic drug treatment, cnsider the frequency, severity, and impact f recurrent cystitis, and whether referral fr urlgical investigatin wuld be apprpriate. Fr recurrent cystitis assciated with sexual intercurse, ffer trimethprim 100 mg t be taken within 2 hurs f intercurse (ff-label use). Fr recurrent cystitis nt assciated with sexual intercurse ffer a 6-mnth trial f lw-dse cntinuus antibitic treatment: trimethprim 100 mg every night, r nitrfurantin (immediate-release) mg every night. In depth Hw shuld I fllw up a wman with recurrent cystitis? If prphylactic antibitics are prescribed, fllw up t review prgress after 6 mnths, r sner if clinically indicated. If haematuria was fund, fllw up t re-test the urine and check that the infectin and haematuria have reslved. In depth When shuld I refer a wman with recurrent cystitis? Refer urgently, t a team specializing in the management f urlgical cancer, if urlgical cancer is suspected (fr example if haematuria persists after successful treatment f acute cystitis). Refer the wman if: Risk factrs fr recurrent cystitis (such as urinary tract abnrmalities, stnes, vesicureteric reflux, papillary necrsis) are present r suspected. There is any knwn abnrmality n ultrasund f kidneys, ureters, and bladder. 7

8 The respnse t preventive treatments and lifestyle measures is ineffective. In depth Prescriptins Antibitic treatment (UTI): trimethprim and nitrfurantin Age frm 14 years nwards Trimethprim tablets: 200mg twice a day fr 3 days Trimethprim 200mg tablets Take ne tablet twice a day fr 3 days. Supply 6 tablets. Age: frm 14 years nwards NHS cst: 0.39 Trimethprim tablets: 200mg twice a day fr 7 days Trimethprim 200mg tablets Take ne tablet twice a day fr 7 days. Supply 14 tablets. Age: frm 14 years nwards NHS cst: 0.91 Nitrfurantin tablets: 50mg fur times a day fr 3 days Nitrfurantin 50mg tablets Take ne tablet fur times a day fr 3 days. Supply 12 tablets. Age: frm 14 years nwards NHS cst: 1.21 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin tablets: 50mg fur times a day fr 7 days Nitrfurantin 50mg tablets Take ne tablet fur times a day fr 7 days. Supply 28 tablets. Age: frm 14 years nwards NHS cst: 2.83 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 50mg fur times a day fr 3 days Nitrfurantin 50mg capsules Take ne capsule fur times a day fr 3 days. Supply 12 capsules. 8 Age: frm 14 years nwards NHS cst: 1.00

9 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 50mg fur times a day fr 7 days Nitrfurantin 50mg capsules Take ne capsule fur times a day fr 7 days. Supply 28 capsules. Age: frm 14 years nwards NHS cst: 2.32 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin m/r caps: 100mg twice a day fr 3 days Nitrfurantin 100mg mdified-release capsules Take ne capsule twice a day fr 3 days. Supply 6 capsules. Age: frm 14 years nwards NHS cst: 2.10 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin m/r caps: 100mg twice a day fr 7 days Nitrfurantin 100mg mdified-release capsules Take ne capsule twice a day fr 7 days. Supply 14 capsules. Age: frm 14 years nwards NHS cst: 4.89 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Antibitic prphylaxis fr recurrent UTIs Age frm 14 years nwards Trimethprim tablets: 100mg at night Trimethprim 100mg tablets Take ne tablet at night. Supply 28 tablets. Nitrfurantin tablets: 50mg at night Nitrfurantin 50mg tablets Take ne tablet at night. Supply 28 tablets. 9 Age: frm 14 years nwards NHS cst: 0.98 Age: frm 14 years nwards NHS cst: 2.48 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 50mg at night Nitrfurantin 50mg capsules

10 Take ne capsule at night. Supply 28 capsules. Age: frm 14 years nwards NHS cst: 2.32 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin tablets: 100mg at night Nitrfurantin 100mg tablets Take ne tablet at night. Supply 28 tablets. Age: frm 14 years nwards NHS cst: 4.34 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 100mg at night Nitrfurantin 100mg capsules Take ne capsule at night. Supply 30 capsules. Age: frm 14 years nwards NHS cst: 4.81 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Antibitic prphylaxis: pst-cital Age frm 16 years nwards Trimethprim tablets: 100mg pst-cital Trimethprim 100mg tablets Take ne tablet within 2 hurs f intercurse. Supply 28 tablets. Age: frm 16 years nwards NHS cst: 0.99 Licensed use: n - ff-label indicatin Analgesia: use when required Age frm 16 years nwards Ibuprfen tablets: 200mg t 400mg three t fur times a day Ibuprfen 200mg tablets Take ne r tw tablets 3 t 4 times a day when required fr pain relief. D nt exceed the stated dse. Supply 56 tablets. Paracetaml tablets: 500mg t 1g up t fur times a day Age: frm 16 years nwards NHS cst: 1.38 OTC cst:

11 Paracetaml 500mg tablets Take ne r tw tablets every 4 t 6 hurs when required fr pain relief. Maximum f 8 tablets in 24 hurs. Supply 50 tablets. Urinary tract infectin (lwer) - wmen - Management Scenari: Asymptmatic bacteriuria and cystitis in wmen wh are pregnant Age: frm 16 years nwards NHS cst: 0.78 OTC cst: 1.35 Hw shuld I screen fr and manage asymptmatic bacteriuria during pregnancy? Screen fr asymptmatic bacteriuria n the first antenatal visit by sending urine fr culture. If asymptmatic bacteriuria is fund, send a secnd urine sample fr culture. If the secnd urine culture cnfirms asymptmatic bacteriuria, treat fr 7 days with an antibitic t which the rganism is sensitive. Preferred ptins when sensitivities are knwn are (in rder f preference): Amxicillin: 250 mg three times daily, fr 7 days. Nitrfurantin: 50 mg fur times daily, r 100 mg (mdified-release) twice daily, fr 7 days. Trimethprim: 200 mg twice daily, fr 7 days (unless the wman is flate deficient r taking a flate antagnist). Cefalexin (500 mg twice daily, r 250 mg 6-hurly, fr 7 days) may be used but is less preferred. After treatment, send urine fr culture t screen fr asymptmatic bacteriuria at every antenatal visit until delivery. If a grup B streptcccus is islated, infrm the antenatal care service, as prphylactic antibitics may be indicated during labur and delivery. In depth Cystitis in pregnancy Hw shuld I manage a pregnant wman with suspected acute cystitis? Cnvey a psitive apprach and reassure the wman that treatment with an antibitic will prevent any harm t her baby, and will shrten the duratin f symptms. 11

12 If the wmen has fever r lin tenderness, suspect upper urinary tract infectin and admit r seek urgent specialist pinin. Offer paracetaml fr symptmatic relief. D nt recmmend urine alkalinizing agents r cranberry prducts. D nt recmmend urine alkalinizing agents r cranberry prducts. Send a urine sample fr culture befre starting antibitic treatment. Prescribe an antibitic empirically. If lcal guidelines are nt available, suitable first-line antibitics are (in rder f preference): Nitrfurantin 50 mg fur times daily, r 100 mg (mdified-release) twice daily, fr 7 days. Trimethprim 200 mg twice daily, fr 7 days (if the persn is nt flate deficient r taking a flate antagnist, and has nt been treated with trimethprim in the past year). Cefalexin 500 mg twice daily, r 250 mg 6-hurly, fr 7 days. Fllw up after 48 hurs (r accrding t the clinical situatin) t check respnse t treatment and the urine culture results. Amxicillin 250 mg three times daily, fr 7 days, is recmmended nly if the rganism is reprted t be susceptible n the culture results. In depth Hw shuld I fllw up a pregnant wman with cystitis? Review culture results when available and, if necessary, change t an antibitic that the rganism is sensitive t. Send urine cultures t screen fr asymptmatic bacteriuria 7 days after cmpletin f treatment, and at every antenatal visit until delivery. If a grup B streptcccus is islated, infrm the antenatal care service, as prphylactic antibitics may be indicated during labur and delivery. In depth When shuld I refer a pregnant wman with cystitis? Admit, r seek urgent specialist pinin, if upper urinary tract infectin is suspected (fever, lin tenderness, and pain). 12

13 Seek specialist advice if symptms fail t respnd t antibitic treatment guided by urine culture results, and if ther causes have been excluded see Differential diagnsis. In depth Hw shuld I manage a pregnant wman whse cystitis has failed t respnd t antibitics? Check cmpliance with antibitic treatment. Cntinue symptmatic treatment with paracetaml r, in the first r secnd trimesters, ibuprfen. Send a urine sample fr culture. If symptms are trublesme, ffer a different antibitic (nitrfurantin r trimethprim) while waiting fr the culture results see Managing suspected acute cystitis during pregnancy. If infectin is cnfirmed n culture, treat with an antibitic t which the rganism is sensitive. If infectin is nt cnfirmed n culture, cnsider ther pssible causes fr the symptms see Differential diagnsis. If cystitis symptms fail t respnd t a secnd antibitic shwn by urine culture results t be apprpriate treatment, seek specialist advice. In depth Prescriptins Antibitics: urinary tract infectin in pregnancy Age frm 14 years nwards Nitrfurantin tablets: 50mg fur times a day fr 7 days Nitrfurantin 50mg tablets Take ne tablet fur times a day fr 7 days. Supply 28 tablets. Age: frm 14 years nwards NHS cst: 2.83 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 50mg fur times a day fr 7 days Nitrfurantin 50mg capsules Take ne capsule fur times a day fr 7 days. Supply 28 capsules. Age: frm 14 years nwards NHS cst:

14 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin m/r caps: 100mg twice a day fr 7 days Nitrfurantin 100mg mdified-release capsules Take ne capsule twice a day fr 7 days. Supply 14 capsules. Age: frm 14 years nwards NHS cst: 4.89 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Trimethprim tablets: 200mg twice a day fr 7 days Trimethprim 200mg tablets Take ne tablet twice a day fr 7 days. Supply 14 tablets. Cefalexin tablets: 250mg fur times a day fr 7 days Cefalexin 250mg tablets Take ne tablet fur times a day fr 7 days. Supply 28 tablets. IF knwn t be sensitive: amxicillin 250mg three times a day fr 7 days Amxicillin 250mg capsules Take ne capsule three times a day fr 7 days. Supply 21 capsules. Cefalexin tablets: 500mg twice a day fr 7 days Cefalexin 500mg tablets Take ne tablet twice a day fr 7 days. Supply 14 tablets. Age: frm 14 years nwards NHS cst: 0.91 Age: frm 14 years nwards NHS cst: 2.19 Age: frm 14 years nwards NHS cst: 0.62 Age: frm 14 years nwards NHS cst: 1.79 Analgesia: use when required (paracetaml nly) Age frm 14 years nwards Paracetaml tablets: 500mg t 1g up t fur times a day Paracetaml 500mg tablets Take ne r tw tablets every 4 t 6 hurs when required fr pain relief. Maximum f 8 tablets in 24 hurs. Supply 50 tablets. 14

15 Age: frm 14 years nwards NHS cst: 0.79 Urinary tract infectin (lwer) - wmen - Management Scenari: Lwer urinary tract infectin in wmen with a chrnic indwelling urinary catheter Hw shuld I treat lwer UTI in a wman with an indwelling catheter? D nt treat asymptmatic bacteriuria. Remember that cnsiderable clinical judgement is required t diagnse urinary tract infectin (UTI) in wmen with an indwelling urinary catheter. If symptms are severe (fr example, severe nausea and vmiting, cnfusin, tachypnea, tachycardia, hyptensin, reduced urine utput), admit t hspital as intravenus antibitics may be required. Check that the catheter is crrectly psitined and nt blcked. If the catheter has been in place fr mre than a week, cnsider changing it befre starting antibitic treatment. If there is fever, r lin pain, r bth, manage as upper UTI, see the CKS tpic n Pyelnephritis - acute. Otherwise, treat fr lwer UTI: Relieve symptms with paracetaml r ibuprfen. Send urine fr culture and micrscpy befre starting antibitic treatment. Prescribe an antibitic fr 7 days, fllwing lcal guidelines when available. If symptms are mild, cnsider withhlding antibitics until the result f urine culture is available t guide chice f antibitic. If symptms are mderate r severe, empirically prescribe an antibitic. Fllw up after 48 hurs (r accrding t the clinical situatin) t check respnse t treatment and the result f urine culture. In depth 15

16 Which antibitic shuld I prescribe empirically fr UTI in a wman with an indwelling urinary catheter? Fllw lcal guidelines when available. Otherwise: Fr empirical treatment, prescribe either: Trimethprim 200 mg twice daily, fr 7 days, r Nitrfurantin 50 mg fur times daily, r 100 mg (mdified-release) twice daily, fr 7 days. If the wman has a histry f recurrent infectins, r has recently (within the past year) taken trimethprim, d nt use trimethprim fr empirical treatment. In depth Hw can I prevent urinary tract infectins in wmen with indwelling catheters? Ensure an indwelling urinary catheter is apprpriate. Use an indwelling catheter nly after alternative methds f management have been cnsidered. Regularly review the clinical need fr catheterizatin and remve the catheter as sn as pssible. Use intermittent catheterizatin in preference t an indwelling catheter if this is clinically apprpriate and is a practical ptin fr the persn. Prevent the intrductin f infectin. Healthcare persnnel shuld be trained and assessed in their cmpetence t perfrm urethral catheterizatin using aseptic prcedures. Urine samples shuld be btained frm a sampling prt using an aseptic technique. Catheters shuld be changed nly when clinically necessary (fr example, t prevent blckage), r accrding t the manufacturer's recmmendatins. When changing catheters, antibitic prphylaxis shuld nly be used fr peple with a histry f catheterassciated urinary tract infectin fllwing catheter change. D nt use: Bladder instillatins r washuts. Prphylactic antibitics when changing catheters in wmen with a heart valve lesin, septal defect, patent ductus, r prsthetic valve. 16

17 Tpical antiseptics r antibitics applied t the catheter, urethra, r meatus; daily washing f the meatus with sap and water is sufficient. In depth Hw shuld I fllw up a wman with an indwelling catheter and treated fr UTI? Review after 48 hurs, r accrding t the clinical situatin, t ensure the wman is respnding t treatment, and t check the results f the urine culture. If urine culture shws that the rganism is resistant t the current antibitic, and: If symptms have nt reslved, change t an antibitic that the rganism is sensitive t. If symptms have reslved, cnsider cntinuing with the current antibitic. If symptms recur, start treat with an antibitic shwn in the culture t cver the infecting rganism. If the wman fails t respnd t tw curses f antibitic shwn by urine culture t be apprpriate treatment, and cmpliance has been checked, cnsider referring fr assessment and investigatin. In depth When shuld I refer a wman with an indwelling catheter and treated fr UTI? Cnsider referring fr assessment and investigatin if the wman fails t respnd t tw curses f antibitic shwn by urine culture t be apprpriate treatment, and cmpliance has been verified. If urlgical cancer is suspected (fr example if haematuria persists after successful treatment f cystitis), refer urgently t a team specializing in the management f urlgical cancer. In depth Prescriptins Antibitics: UTI in wmen with catheters Age frm 14 years nwards Trimethprim tablets: 200mg twice a day fr 7 days Trimethprim 200mg tablets Take ne tablet twice a day fr 7 days. Supply 14 tablets. Nitrfurantin tablets: 50mg fur times a day fr 7 days 17 Age: frm 14 years nwards NHS cst: 0.91

18 Nitrfurantin 50mg tablets Take ne tablet fur times a day fr 7 days. Supply 28 tablets. Age: frm 14 years nwards NHS cst: 2.83 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin capsules: 50mg fur times a day fr 7 days Nitrfurantin 50mg capsules Take ne capsule fur times a day fr 7 days. Supply 28 capsules. Age: frm 14 years nwards NHS cst: 2.32 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Nitrfurantin m/r caps: 100mg twice a day fr 7 days Nitrfurantin 100mg mdified-release capsules Take ne capsule twice a day fr 7 days. Supply 14 capsules. Age: frm 14 years nwards NHS cst: 4.89 Patient infrmatin: This medicine may cause yur urine t turn mre yellw than nrmal. Analgesia: use when required Age frm 16 years nwards Ibuprfen tablets: 200mg t 400mg three t fur times a day Ibuprfen 200mg tablets Take ne r tw tablets 3 t 4 times a day when required fr pain relief. D nt exceed the stated dse. Supply 56 tablets. Paracetaml tablets: 500mg t 1g up t fur times a day Age: frm 16 years nwards NHS cst: 1.38 OTC cst: 2.38 Paracetaml 500mg tablets Take ne r tw tablets every 4 t 6 hurs when required fr pain relief. Maximum f 8 tablets in 24 hurs. Supply 50 tablets. Urinary tract infectin (lwer) - wmen - Management Detailed answers Age: frm 16 years nwards NHS cst: 0.78 OTC cst:

19 Overview f management Acute cystitis in nn-pregnant wmen Cnvey a psitive apprach and reassure the wman that cystitis is generally self-limiting. Relieve the symptms with paracetaml r ibuprfen. If cystitis symptms are mderate r severe, ffer a 3-day curse f: Trimethprim 200 mg twice daily, r Nitrfurantin 50 mg fur times a day, r 100 mg (mdified-release) twice daily. If cystitis symptms are mild: Dipstick test the urine and if results are negative, discuss nt treating the cystitis with an antibitic. Have a lwer threshld fr ffering an antibitic if there are risk factrs fr persistent infectin, recurrent infectin, r treatment failure. If there are cncerns abut nt taking an antibitic, ffer a delayed antibitic prescriptin t be dispensed if the symptms becme wrse, r last mre than 48 hurs. Urine culture is nt rutinely required. Urine culture is useful t cnfirm the diagnsis and t guide chice f antibitic when there are risk factrs fr mre severe illness r treatment has failed. If cystitis symptms fail t respnd t an antibitic chsen accrding t the urine culture result, check cmpliance, repeat the urine culture, change t anther antibitic, and cnsider referring fr specialist assessment. Recurrent cystitis Review the diagnsis. Review the medical and surgical histry t assess risk factrs fr recurrent cystitis such as stnes, papillary necrsis, and vesicureteric reflux this may require imaging r urlgical referral. Relieve the symptms with paracetaml r ibuprfen. Treat the infectin with a 3-day curse f trimethprim r nitrfurantin (as abve) if the symptms are severe. 19

20 Advise n lifestyle measures fr preventin, such as use f cranberry prducts. High strength (at least 200 mg) capsules may be mre effective and better tlerated than cranberry drinks. Fr wmen with trublesme recurrent cystitis, cnsider: A prescriptin fr a 'stand-by' antibitic t be used fr future episdes f cystitis. Trimethprim 200 mg t be taken within 2 hurs f intercurse (ff-label use). A 6-mnth trial f lw-dse cntinuus antibitic treatment: trimethprim 100 mg r nitrfurantin (immediaterelease) mg, every night. Asymptmatic bacteriuria in pregnancy Screen fr asymptmatic bacteriuria n the first antenatal visit by sending urine fr culture. If asymptmatic bacteriuria is fund, send a secnd urine sample fr culture. If the secnd urine culture cnfirms asymptmatic bacteriuria, treat fr 7 days with an antibitic t which the rganism is sensitive. D nt use trimethprim first-line if there is a suitable alternative. After treatment, send urine fr culture t screen fr asymptmatic bacteriuria at every antenatal visit until delivery. If a grup B streptcccus is islated, infrm the antenatal care service, as prphylactic antibitics may be indicated during labur and delivery. Cystitis during pregnancy Culture the urine. Relieve the symptms with paracetaml. Treat the infectin with an apprpriate antibitic fr 7 days (in rder f preference: nitrfurantin, trimethprim [if the wman is nt flate deficient r taking a flate antagnist], amxicillin, cefalexin). Have a lw threshld fr admitting the wman if upper urinary tract infectin (UTI) is suspected (fever, lin tenderness, and pain). After treatment, send urine fr culture t screen fr asymptmatic bacteriuria at every antenatal visit until delivery. If a grup B streptcccus is islated, infrm the antenatal care service, as prphylactic antibitics may be indicated during labur and delivery. 20

21 Lwer UTI in wmen with an indwelling urinary catheter Fr wmen with an indwelling urinary catheter, cnsiderable clinical judgement is required t diagnse UTI. Assess the severity f the infectin and the presence f any cmrbidities. Admit the wman t hspital if there are symptms and signs f severe infectin. If there is fever, and flank pain r tenderness, manage as fr upper UTI see the CKS tpic n Pyelnephritis - acute. Check that the catheter is crrectly psitined and nt blcked. Send urine fr culture befre antibitic treatment is started. If it is practical, withhld antibitics until the result f urine culture is available t guide the chice f antibitic. Otherwise, empirically prescribe trimethprim r nitrfurantin fr 7 days. Relieve the symptms with paracetaml r ibuprfen. Check the urine culture reprt. If necessary, change the antibitic t ne t which the rganism is sensitive. T prevent UTI: Use an indwelling urinary catheter nly after alternative methds f management have been cnsidered, and regularly review the need fr a catheter. Ensure high standards f hygiene with catheter care: btain urine samples frm a sampling prt using an aseptic technique, and change catheters nly when necessary. When changing catheters, nly use antibitic prphylaxis fr peple with a histry f catheter-assciated UTI fllwing catheter change. Acute cystitis (nt pregnant) Hw shuld I manage a wman with suspected cystitis? Cnvey a psitive apprach and reassure the wman that cystitis is generally self-limiting: Withut antibitics, symptms can be expected t reslve in 4 9 days. With antibitics, symptms can be expected t reslve in 3 8 days. On average, antibitics shrten the duratin f symptms by abut a day. 21

22 Relieve symptms with paracetaml r ibuprfen d nt recmmend urine alkalinizing agents r cranberry prducts. If cystitis symptms are mderate r severe: Offer an antibitic. D nt dipstick test the urine, as the decisin t ffer an antibitic is nt influenced by urine dipstick test results. Even if the tests fr nitrite, and leuccyte esterase, and bld are all negative, an antibitic shuld still be ffered. If the wman prefers nt t take an antibitic, ffer a delayed antibitic prescriptin t be dispensed if the symptms becme wrse, r last mre than 48 hurs. If cystitis symptms are mild: Dipstick test the urine t guide treatment decisins. Discuss nt using an antibitic, especially if the urine dipstick test is negative fr nitrites and leuccyte esterase and bld. Have a lwer threshld fr ffering an antibitic if there are risk factrs fr persistent infectin, recurrent infectin, r treatment failure. If there are cncerns abut nt taking an antibitic, ffer a delayed antibitic prescriptin t be dispensed if the symptms becme wrse, r last mre than 48 hurs. Advise the wman t seek medical attentin if she develps a high fever r becmes systemically unwell. Basis fr recmmendatin These recmmendatins are in line with Scttish [SIGN, 2006], Eurpean [Eurpean Assciatin f Urlgy, 2009], and American [ICSI, 2004; American Cllege f Obstetricians and Gyneclgists, 2008] guidelines. The recmmendatins als take int accunt the evidence frm a Health Technlgy Assessment (HTA) cmmissined by the Natinal Institute fr Health Research (NIHR) t assess the diagnsis f cystitis, its prgnsis, and five different treatment strategies [Little et al, 2009]. A psitive apprach t prgnsis 22

23 A psitive apprach t diagnsis and prgnsis has been fund t be independently assciated with shrter duratin f symptms in bservatinal studies and in randmized cntrlled trials [Thmas, 1987; Little et al, 2001; Little et al, 2009]. The average duratin f symptms (that are at least mderately severe) is reprted in the NIHR HTA [Little et al, 2009] and summarized in the Prgnsis sectin. Use f an analgesic fr symptmatic relief CKS fund n trials f analgesics fr the painful symptms f cystitis. The recmmendatin t use paracetaml r ibuprfen t treat the painful symptms f cystitis is based n their use in ther painful infectins and the experience f experts [SIGN, 2006]. There is insufficient evidence t recmmend the use f: Urine alkalinizing agents (such as ptassium citrate r bicarbnate): CKS fund n cntrlled trials f urine alkalinizing agents. One bservatinal study fund n relatinship between symptms f cystitis and urine ph [Brumfitt et al, 1990]. Cranberry prducts: a Cchrane systematic review fund n gd evidence t supprt the use f cranberry juice r ther cranberry prducts fr treating acute UTIs [Jepsn et al, 1998]. Treatment strategy (t cnsider the ptins f an antibitic, n antibitic, r delayed antibitic prescriptin) The evidence that a curse f antibitics is effective is discussed in Chice f antibitic. The strategy fr antibitic prescribing is supprted by evidence frm a series f studies in the UK [Little et al, 2009], and a randmized cntrlled trial in New Zealand [Richards et al, 2005]. N clinically (r ecnmically) imprtant differences were fund between five different treatment strategies in which antibitics were ffered: (i) immediately, (ii) delayed fr 48 hurs, (iii) accrding t a symptm rule, (iv) accrding t a dipstick test rule, r (v) accrding t the results f urine culture. Wmen wh did nt meet the criteria fr immediate antibitic treatment were ffered a delayed antibitic prescriptin t use if their symptms did nt settle after 48 hurs. In each grup where wmen were ffered a delayed prescriptin, a high prprtin chse t use it. Wmen wh presented with mre severe symptms f dysuria, urgency, frequency, and ncturia recvered mre slwly. Antibitics shrtened the duratin f symptms (that were at least mderately severe) by abut 1 2 days. 23

24 CKS therefre recmmends ffering an antibitic when: Presenting symptms are mderate r severe because antibitics are likely t shrten the duratin f symptms by 1 2 days. The wman has a strng preference fr antibitic treatment because there is n evidence that treatment leads t prer utcmes, althugh there is als n evidence f effectiveness in wmen with less severe symptms. It may be a cmplicated infectin because there is a greater risk f adverse effects frm infectin. While CKS recmmends using severity f symptms as a key decisin criterin, ther guidelines (fr example [SIGN, 2006]) recmmend using number f symptms. CKS recmmends cnsidering a delayed antibitic prescriptin whenever an antibitic is nt prescribed, because this may give sme wmen the cnfidence needed t try nt using an antibitic, t see if the symptms reslve spntaneusly. When prescribing empirically fr acute cystitis which antibitic shuld I chse? Fllw lcal guidelines when available. If lcal guidelines are nt available: Fr an uncmplicated infectin, prescribe either: Trimethprim 200 mg twice daily, fr 3 days, r Nitrfurantin 50 mg fur times daily, r 100 mg (mdified-release) twice daily, fr 3 days. Fr a cmplicated infectin, prescribe a 5 10-day curse f trimethprim r nitrfurantin. Basis fr recmmendatin Antibitic treatment Fr wmen with urinary tract infectin (UTI), there is evidence frm a meta-analysis that antibitics are mre effective than placeb in eradicating bacteriuria and relieving UTI symptms [Falagas et al, 2009]. Duratin f antibitic treatment A 3-day curse f empirical treatment is recmmended because there is gd evidence frm Cchrane systematic reviews that this achieves symptmatic cure in peple with uncmplicated UTI; it is mre effective than single-dse treatment and as effective as 5 10-day curses. This is als in line with 24

25 recmmendatins frm the Scttish Intercllegiate Guidelines Netwrk (SIGN) [SIGN, 2006] and internatinal guidelines [American Cllege f Obstetricians and Gyneclgists, 2008; Eurpean Assciatin f Urlgy, 2009]. Fr peple with a cmplicated UTI, a lnger curse is recmmended because there is evidence frm a Cchrane systematic review that a 5 10-day curse prduced a higher bacterilgical cure rate (but mre adverse effects) than a 3-day regimen. The Cchrane systematic review cncluded that a 5 10-day curse may be cnsidered fr wmen in whm eradicatin f bacteriuria is imprtant. Rute f administratin The ral rute is recmmended, even fr severe cystitis. A Cchrane systematic review fund n evidence that ral antibitic treatment is less effective than intravenus antibitics fr treating severe UTIs [Phl, 2007]. Antibitic chice: trimethprim and nitrfurantin as first-line ptins Trimethprim and nitrfurantin (bth narrw spectrum antibitics) are generally recmmended as apprpriate first-line antibitics in the UK [SIGN, 2006; BNF 57, 2009]. Narrw spectrum antibitics are preferred ver brad spectrum antibitics such as c-amxiclav, quinlnes, and cephalsprins. This is in line with guidance issued by the Health Prtectin Agency which recmmends aviding the use f brad spectrum antibitics when narrw spectrum antibitics remain effective [HPA, 2009]. There are cncerns that brad spectrum antibitics increase the risk f Clstridium difficile, meticillin-resistant Staphylcccus aureus (MRSA), and resistant UTIs. Issues f antibitic resistance are discussed belw. Despite their widespread use, there are few cmparative trials cmparing these tw antibitics. There is evidence frm fur trials which fund trimethprim and nitrfurantin t be equally effective and generally well tlerated. The dsages recmmended are based n thse recmmended by the manufacturers f these antibitics and are in line with dses used in trials [Gldshield Pharmaceuticals, 2002a; Gldshield Pharmaceuticals, 2002b; Actavis, 2007]. Bacterial resistance There are cncerns that resistance t trimethprim and nitrfurantin is increasing, yet few data n the resistance patterns have been published. 25

26 Evidence frm lder studies indicated trimethprim resistance t be arund 20 30% (althugh higher levels have been reprted fr certain parts f the UK) with a lwer incidence fr nitrfurantin (less than 20%). Hwever, these data shuld be treated with cautin, because: Mst f these studies were perfrmed in the 1990s and resistance patterns may have changed. There are cnsiderable gegraphic variatins in antibitic resistance pattern. It is difficult t cmpare results frm different studies because f differences in ppulatins (fr example hspital r cmmunity) and differences in labratry standards. Rates f clinical resistance t trimethprim may be less cmmn than expected frm rates f resistance in labratry samples. Statistics frm labratries are likely t be biased by higher prprtins f samples frm wmen with resistant infectins [McNulty et al, 2006]. Cnsequently, CKS recmmends that, where available, lcal antibitic guidelines shuld be fllwed, taking int accunt lcal resistance patterns. Nitrfurantin frmulatins Bth immediate and mdified-release frmulatins f nitrfurantin are recmmended because CKS fund n evidence t prefer ne frmulatin ver anther. Fr further infrmatin, see Dsage. When shuld I culture the urine f a wman with suspected cystitis? Urine micrscpy and culture are nt rutinely required fr wmen with uncmplicated cystitis. Send urine fr micrscpy and culture if any f the fllwing apply: There are risk factrs fr a cmplicated urinary tract infectin fr example the wman has recently had urlgical instrumentatin, r is immuncmprmised, r has been in hspital recently. Cnfirmatin f the diagnsis r exclusin f ther cnditins is required. The wman has nt respnded t antibitic treatment. The wman has recurrent episdes f cystitis and this has nt been investigated. When underlying causes f recurrent cystitis and ther cnditins have been excluded, it is nt necessary t rutinely culture the urine fr further episdes. Basis fr recmmendatin 26

27 These recmmendatins are in line with Scttish Intercllegiate Guidelines Netwrk guidelines [SIGN, 2006]. Urine culture Urine culture is mainly useful fr identifying bacteria and their sensitivity t antibitics [SIGN, 2006]. Urine micrscpy and culture are nt rutinely recmmended fr wmen with uncmplicated cystitis because the results are nt available fr immediate decisin-making and, by the time they are available, mst wmen's symptms will be reslving. Three studies fund that, if urine were t be rutinely cultured fr all wmen with acute cystitis, the average duratin f symptms wuld be reduced by between 0.04 and 0.32 days [SIGN, 2006]. Similar evidence is prvided by a randmized cntrlled trial that cmpared different strategies fr antibitic treatment [Little et al, 2009]. An ecnmic analysis estimated the cst f preventing 1 day f symptms as 215, and the cst per QALY (quality adjusted life year gained) was 215,000 [SIGN, 2006]. Urine culture is recmmended fr wmen with a cmplicated infectin because the risks assciated with treatment failure are increased [SIGN, 2006]. Hw shuld I fllw up a wman with cystitis? Fllw up is nt rutinely required fr uncmplicated cystitis, but shuld be cnsidered fr wmen with a ptentially cmplicated infectin. If haematuria was fund, fllw up t re-test the urine and check that the infectin and haematuria have reslved. Basis fr recmmendatin This recmmendatin is pragmatic as CKS fund n published evidence n which t base recmmendatins [SIGN, 2006]. Fllw up is nt rutinely required fr uncmplicated cystitis as mst cases f uncmplicated urinary tract infectin reslve in abut 4 9 days withut antibitic treatment, and in abut 3 8 days with antibitic treatment see Prgnsis. When shuld I refer a wman with acute cystitis? 27

28 If the wman fails t respnd t tw curses f antibitics shwn by urine culture results t be apprpriate treatment, refer fr specialist assessment. If urlgical cancer is suspected (fr example haematuria persists after successful treatment f cystitis), refer urgently t a team specializing in the management f urlgical cancer. Basis fr recmmendatin Referral fr failure t respnd t apprpriate antibitics The recmmendatin t cnsider referring wmen wh have failed t respnd t an apprpriate antibitic (shwn by urine culture) is pragmatic, as there is n direct evidence frm clinical trials r recmmendatins in natinal guidelines. Urgent referral fr urlgical cancer The recmmendatin t refer wmen with suspected urlgical cancer is based n criteria in guidelines frm the Natinal Institute fr Health and Clinical Excellence [NICE, 2005b]. Hw shuld I manage a wman whse cystitis has failed t respnd t antibitics? Cntinue symptmatic treatment with paracetaml r ibuprfen. Check cmpliance with antibitic treatment. Send a urine sample fr culture. If symptms are trublesme, ffer a different antibitic (nitrfurantin r trimethprim) while waiting fr the culture results see Chice f antibitic. If infectin is cnfirmed n culture, treat with an antibitic t which the rganism is sensitive. If infectin is nt cnfirmed n culture, cnsider ther pssible causes fr the symptms see Differential diagnsis. If cystitis symptms fail t respnd t tw curses f antibitic shwn by culture t be apprpriate treatment, refer fr specialist assessment. Basis fr recmmendatin 28

29 These recmmendatins are in line with guidance frm the Scttish Intercllegiate Guidelines Netwrk [SIGN, 2006]. The recmmendatin t ffer a different antibitic if symptms persist is supprted by a study f the curse f uncmplicated cmmunity-acquired urinary tract infectin in wmen [McNulty et al, 2006]. The study fund that, after 5 days f antibitic treatment, symptms had reslved in 70% f wmen infected with an rganism sensitive t the antibitic, and 24% f wmen with a resistant islate. The study als fund that 50% f thse wh recnsulted in the first week had a resistant islate. Recurrent cystitis in wmen wh are nt pregnant Hw shuld I manage an acute episde f recurrent cystitis? Review the diagnsis. Culture the urine t cnfirm infectin and exclude ther causes. Refer urgently if urlgical cancer is suspected. Review the wman's medical and surgical histry t assess risk factrs fr recurrent cystitis such as stnes, papillary necrsis, and vesicureteric reflux this assessment may require imaging and urlgical referral. Relieve symptms with paracetaml r ibuprfen. If symptms are mderate r severe, ffer an antibitic immediately. If symptms are mild, suggest delaying antibitic treatment until culture results are available t guide chice f antibitic. Advise n lifestyle measures such as high-strength cranberry capsules t reduce the risk f recurrent episdes. If trublesme cystitis recurs frequently: Cnsider ffering a prescriptin fr a 'stand-by' antibitic t be used fr future episdes. Cnsider preventive treatments. Refer r seek specialist advice if these measures are nt successful. Basis fr recmmendatin Cnfirming urinary tract infectin and excluding ther causes 29

30 The recmmendatin t cnfirm infectin with urine culture, and exclude ther causes, is pragmatic. The recmmendatin t refer urgently if cancer is suspected is based n guidelines frm the Natinal Institute fr Health and Clinical Excellence [NICE, 2005b]. Treatments The basis fr recmmending symptmatic relief with paracetaml r ibuprfen is discussed in Managing suspected cystitis. The basis fr ffering empirical antibitic treatment if symptms are mderate r severe, r delaying treatment if symptms are mild, is discussed in Managing suspected cystitis. The recmmendatin t cnsider 'stand-by' antibitics is based n expert pinin [Harris et al, 2008]. Lifestyle measures and preventive treatment The basis fr lifestyle measures and prphylactic treatments is discussed in the sectins n Lifestyle measures and Preventive treatments. Referral The basis fr the recmmendatin t refer the wman if prphylactic measures are unsuccessful is pragmatic. Which antibitic shuld I prescribe fr a wman with recurrent cystitis? Fllw lcal guidelines when available. Otherwise: Fr empirical treatment, prescribe either: Trimethprim 200 mg twice daily, fr 3 days, r Nitrfurantin 50 mg fur times daily, r 100 mg (mdified-release) twice daily, fr 3 days. If the wman has been treated with trimethprim recently (up t a year previusly), cnsider prescribing nitrfurantin instead f trimethprim. Basis fr recmmendatin Chice f antibitic 30

31 The reasns fr preferring trimethprim and nitrfurantin as first-line ptins fr treating cystitis are discussed in Chice f antibitic. Cnsidering nitrfurantin when trimethprim has been used recently Nitrfurantin may be preferable fr empirical prescribing when the wman has recently used trimethprim because there is evidence that urpathgens are mre likely t be resistant t trimethprim if it has been used recently (up t the past year). The evidence is nt clear enugh t recmmend precise threshlds f expsure. Trimethprim is nt preferred when nitrfurantin has previusly been used because there is n evidence that previus treatment with nitrfurantin increases the chance that future infectins will be resistant rganisms. Furthermre, labratry studies find that nitrfurantin-resistant Escherichia cli reprduce substantially less effectively than nitrfurantin-sensitive E. cli (in ther wrds, nitrfurantin resistance impses a high fitness cst n the rganism) [Sandegren et al, 2008]. What lifestyle measures shuld I advise fr preventing cystitis? Advise wmen with recurrent cystitis that: Cranberry prducts reduce the recurrence rate f cystitis, and are available frm shps (but nt n the NHS). Cranberry prducts shuld nt be taken if warfarin is being used. High strength capsules (cntaining at least 200 mg f cranberry extract) are recmmended because: They may be mre effective than cranberry drinks, which require a large vlume t be drunk t prvide the same amunt f cranberry extract: 200 mg f cranberry extract is equivalent t abut 5000 mg f fresh cranberries. Cranberry capsules may be mre acceptable than cranberry juice, which sme wmen find difficult t take regularly because f the bitter taste r the large amunt f sugar added t mask the bitterness. If cystitis is related t sexual intercurse, ptins t be cnsidered include: A different cntraceptive methd, if a diaphragm is being used. Viding sn after intercurse. Using a lubricant if symptms culd be due t mild trauma rather than infectin. Basis fr recmmendatin 31

32 Cranberry extract fr preventing cystitis There is gd evidence that cranberry prducts effectively prevent cystitis. A Cchrane systematic review f randmized cntrlled trials fund that cranberry prducts significantly reduced the incidence f urinary tract infectins (UTIs) ver 12 mnths, cmpared with placeb r cntrl treatments. Hwever, withdrawal rates in the trials were high, which may indicate that many wmen find taking cranberry prducts unacceptable in the lng term. Als, the benefits f cranberry may be less in elderly wmen and wmen with a urinary catheter. The ptimal dse and frm f administratin f cranberry prducts is nt established. Hwever, higher dses may be mre effective than lwer dses [SIGN, 2006]. Cranberry prducts shuld be avided by peple taking warfarin, as they can ptentiate its effects [CSM, 2003; CSM, 2004]. Recurrent cystitis related t sexual intercurse These recmmendatins are based n expert pinin [Harris et al, 2008]. The Scttish Intercllegiate Guidelines Netwrk (SIGN) guidelines explain that because 'there is n cnclusive assciatin between lifestyle factrs, such as diet, hydratin, clthing, tileting activity, and sexual activity, and susceptibility t bacterial UTI in adult, nn-pregnant wmen, there is n evidence t supprt healthcare prfessinals giving rutine advice abut lifestyle factrs' [SIGN, 2006]. The incidence f UTI may be increased in wmen wh use diaphragms this may relate t the fit and size f the diaphragm putting pressure n the urethra. The incidence f UTI may als be increased in wmen wh use spermicides, but the use f spermicides with cndms is n lnger recmmended. Fr further infrmatin, see the sectins n Diaphragm and cap, and Male cndm in the CKS tpic n Cntraceptin. When shuld I ffer preventive treatments fr recurrent cystitis? Cnsider ffering a prescriptin fr a 'stand-by' antibitic t be used fr future episdes f cystitis befre prescribing prphylactic drug treatment. When deciding t ffer prphylactic drug treatment, cnsider the frequency, severity, and impact f recurrent cystitis, and whether referral fr urlgical investigatin wuld be apprpriate. Fr recurrent cystitis assciated with sexual intercurse: Offer trimethprim 100 mg t be taken within 2 hurs f intercurse (ff-label use). 32

Prostatitis - chronic - Management

Prostatitis - chronic - Management Prstatitis - chrnic - Management Scenari: Diagnsis f chrnic prstatitis Hw shuld I diagnse chrnic prstatitis? Diagnse chrnic prstatitis if: The man has pain in the perineum r pelvic flr and lwer urinary

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review: Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

Significance of Chronic Kidney Disease in 2015

Significance of Chronic Kidney Disease in 2015 1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

DRAFT Policy for the Management of Ear Wax

DRAFT Policy for the Management of Ear Wax Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

Tick fever is a cattle disease caused by any one of the following blood parasites:

Tick fever is a cattle disease caused by any one of the following blood parasites: Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

BRCA1 and BRCA2 Mutations

BRCA1 and BRCA2 Mutations BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease

More information

CDC Influenza Division Key Points November 7, 2014

CDC Influenza Division Key Points November 7, 2014 In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines

More information

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride

More information

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated

More information

BP Thresholds for Medical Review

BP Thresholds for Medical Review BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,

More information

Frequently asked questions: Influenza A (H1N1)v

Frequently asked questions: Influenza A (H1N1)v July 30 th 2009 V1.0 Frequently asked questins: Influenza A (H1N1)v (Swine Flu) infrmatin fr parents The fllwing advice is fr parents f children in all educatinal institutins, including crèches, childcare,

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

H1N1 Influenza 09 Guidance for Residential Aged Care

H1N1 Influenza 09 Guidance for Residential Aged Care H1N1 Influenza 09 Guidance fr Residential Aged Care 11 June 2009 As knwledge abut H1N1 Influenza 09 develps, further advice will be prvided. Please check www.healthemergency.gv.au fr the latest infrmatin.

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

A fake medicine that passes itself off as a real, authorised medicine. (1)

A fake medicine that passes itself off as a real, authorised medicine. (1) Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have

More information

decreased when the man lies down. The varicocele cannot usually be palpated lying down.

decreased when the man lies down. The varicocele cannot usually be palpated lying down. Variccele - Management View full scenari Hw d I knw my patient has a variccele? The man may present with cncern abut scrtal swelling r scrtal pain, r a variccele may be an incidental finding n physical

More information

ALCAT FREQUENTLY ASKED QUESTIONS

ALCAT FREQUENTLY ASKED QUESTIONS 1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age

More information

Adult Preventive Care Guidelines

Adult Preventive Care Guidelines Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether

More information

MEDICATION GUIDE. (fingolimod) capsules

MEDICATION GUIDE. (fingolimod) capsules MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

MEDICATION GUIDE. Reference ID:

MEDICATION GUIDE. Reference ID: MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher: Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:

More information

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to: PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If

More information

Before Your Visit: Mohs Skin Cancer Surgery

Before Your Visit: Mohs Skin Cancer Surgery Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

The research question: What was discovered in the 1940s that could treat syphilis?

The research question: What was discovered in the 1940s that could treat syphilis? Psychlgy B30 Human Sexuality Sexually Transmitted Infectins Tuskegee Syphilis Experiment Ppulatin: The research questin: What was discvered in the 1940s that culd treat syphilis? Hw many men died f syphilis

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems. PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr

More information

Percutaneous Nephrolithotomy (PCNL)

Percutaneous Nephrolithotomy (PCNL) Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this

More information

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII) Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause

More information

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation Kent and Medway Plicy Recmmendatin and Guidance Cmmittee Plicy Recmmendatin Plicy: PR 2017-11: Surgery fr haemrrhids Issue date: July 2017 Review date: July 2020 The Kent and Medway Plicy Recmmendatin

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Hospital Preparedness Checklist

Hospital Preparedness Checklist Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been

More information

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant

More information

Response to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines

Response to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines Respnse t type 2 vaccine-derived pliviruses prir t glbal topv withdrawal Interim Guidelines August 2015 GPEI peratinal guidance nte August 2015 Summary Prepare fr prmpt actin fr any area r ppulatin at

More information

Tendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones.

Tendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones. Medicatin Guide LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION, 25 mg/ml and LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION in 5% Dextrse fr Intravenus Use Read this Medicatin Guide befre yu start taking levflxacin

More information

MEDICATION GUIDE. (canagliflozin) Tablets

MEDICATION GUIDE. (canagliflozin) Tablets MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

2. How are screening and diagnostic mammograms different?

2. How are screening and diagnostic mammograms different? Mammgrams cmprises public dmain material frm the Natinal Cancer Institute at the Natinal Institutes f Health, an agency f the U.S. Department f Health and Human Services. Mammgrams Key Pints A mammgram

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,

More information

Name of procedure: Removal of submandibular salivary gland

Name of procedure: Removal of submandibular salivary gland Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu

More information

Widening of funding restrictions for rituximab and eltrombopag

Widening of funding restrictions for rituximab and eltrombopag 20 February 2014 Widening f funding restrictins fr rituximab and eltrmbpag PHARMAC is pleased t annunce the apprval f prpsals t widen the restrictin n rituximab use in DHB hspitals and expand the funding

More information

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties

More information

Generic Immunosuppressants in the Specialist Area of Transplantation Consensus on Implications and Practical Recommendations

Generic Immunosuppressants in the Specialist Area of Transplantation Consensus on Implications and Practical Recommendations Dear Clleague Generic Immunsuppressants in the Specialist Area f Transplantatin Cnsensus n Implicatins and Practical Recmmendatins Executive Summary Slid-rgan transplants are the best pssible treatment

More information

Specifically, on page 12 of the current evicore draft, we find the statement:

Specifically, on page 12 of the current evicore draft, we find the statement: Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit

More information

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains

More information

Lower urinary tract symptoms in men, age-related (including symptoms of benign prostatic hyperplasia/hypertrophy) - Management

Lower urinary tract symptoms in men, age-related (including symptoms of benign prostatic hyperplasia/hypertrophy) - Management Lwer urinary tract symptms in men, age-related (including symptms f benign prstatic hyperplasia/hypertrphy) - Management Scenari: Initial assessment f lwer urinary tract symptms (LUTS) Hw shuld I characterize

More information

MEDICATION GUIDE Levofloxacin (lee-voe-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets

MEDICATION GUIDE Levofloxacin (lee-voe-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets MEDICATION GUIDE Levflxacin (lee-ve-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets Read this Medicatin Guide befre yu start taking levflxacin tablets and each time yu get a

More information

5.0: Rare Bleeding Disorders

5.0: Rare Bleeding Disorders 5.0: Rare Bleeding Disrders 5.1: General Infrmatin Rare bleeding disrders (RBDs) include deficiencies f factrs I (Fibringen), II, V, VII, X, XI and XIII. These deficiencies can be severe r mild. Severe

More information

iprex Fact Sheet: Key Results

iprex Fact Sheet: Key Results EMBARGOED UNTIL RELEASE Tuesday, 23 Nvember 2010, 8 a.m. EST CONTACT Mark Aurigemma; 646-270-9451; mark@aucmm.net Pedr Gicchea; 415-490-8350 pgicchea@gladstne.ucsf.edu iprex Fact Sheet: Key Results iprex

More information

/0515 Medication Guide Aripiprazole Tablets

/0515 Medication Guide Aripiprazole Tablets 8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This

More information

Zika Virus. Where has Zika virus been found? Zika in the United States and its territories:

Zika Virus. Where has Zika virus been found? Zika in the United States and its territories: Where has Zika virus been fund? Zika Virus Prir t 2015, Zika virus utbreaks have ccurred in areas f Africa, Sutheast Asia, and the Pacific Islands. In May 2015, the Pan American Health Organizatin (PAHO)

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following: RADIOGRAPHY OF THE ANKLE AND FOOT (OTTAWA ANKLE RULES) Clinical Practice Guideline January 2007 This guideline has been adapted frm the Ottawa Ankle Rules develped by Dr. Ian Stiell et al. Dr. Stiell received

More information

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains

More information

The data refer to persons aged between 15 and 54.

The data refer to persons aged between 15 and 54. Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information